MELBOURNE, Australia, April 16, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces successful preclinical development of radiolabelled olaratumab, an antibody licensed from Eli Lilly and Company (Lilly). Telix has demonstrated…
Month: April 2023
MELBOURNE, Australia, April 16, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces successful preclinical development of radiolabelled olaratumab, an antibody licensed from Eli Lilly and Company (Lilly). Telix has demonstrated…
New Stand-Alone SSAI SaaS Boasts an Open Ecosystem for Targeted Advertising SAN JOSE, Calif., April 16, 2023 /PRNewswire/ — Harmonic (NASDAQ: HLIT) today announced that it has launched VOS®360 Ad, an innovative, stand-alone, server-side ad insertion (SSAI) SaaS that is fully cloud-based,…
Harmonic’s XOS Software Improves Bandwidth Efficiency for NEXTGEN TV SAN JOSE, Calif., April 16, 2023 /PRNewswire/ — Harmonic (NASDAQ: HLIT) today announced growing momentum for its XOS software-based advanced media processing solution as ATSC 3.0 deployments skyrocket across the U.S….
New Partnership with Spideo Offers FAST Channel Scheduling and Groundbreaking Content Personalization SAN JOSE, Calif., April 16, 2023 /PRNewswire/ — Harmonic (NASDAQ: HLIT) today announced that it has further expanded its cloud playout ecosystem and automated the creation of FAST…
Premium Streaming Service Leverages Powerful Cloud Playout Capabilities of Harmonic’s VOS360 Media SaaS SAN JOSE, Calif., April 16, 2023 /PRNewswire/ — Harmonic (NASDAQ: HLIT) today announced that Bally’s Interactive, the digital arm of one of the world’s leading entertainment providers,…
Harmonic’s VOS360 SaaS Enables Pristine Video Quality and Targeted Ad Delivery at Scale SAN JOSE, Calif., April 16, 2023 /PRNewswire/ — Harmonic (NASDAQ: HLIT) today announced that MSG Networks will use Harmonic’s VOS®360 SaaS for its new MSG+ sports streaming service, due to launch this…
Data support DHX9 inhibition as a novel therapeutic modality in microsatellite instable colorectal cancer and describe the first identification of potent and selective small molecule inhibitors of DHX9 Proprietary crystal structures of DHX9 enable rapid, structure-based drug discovery for…
GUANGZHOU, China, April 16, 2023 /PRNewswire/ — Midea, a leading brand in smart home appliances, has debuted its latest intelligent energy management solution, the Midea Home Energy Linkage Inverter Optimization System (MHELIOS) at the 133rd Canton Fair, one of the world’s pinnacle…
First-in-Class TEAD Autopalmitoylation Inhibitor is Well Tolerated and Demonstrates Antitumor Activity in Advanced Mesothelioma and NF2-Mutant Cancers VT3989 is the First Therapeutic Targeting the Hippo Pathway to Demonstrate Clinical Activity in Patients with Cancer SAN MATEO, Calif.,…